Insider · CIK 0001388773

Clague Laura

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001388773

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-14	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+35.4K sh	—	—	35,380
2023-06-14	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+26.4K sh	—	—	104,791
2022-06-15	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+42.6K sh	—	—	42,571
2022-06-15	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+30.9K sh	—	—	78,415
2022-05-11	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,375 sh	$21.51	−$29.6K	35,655
2022-05-10	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−825 sh	$21.51	−$17.7K	37,030
2022-04-27	GNSSGenasys Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.33	+$66.5K	284,311
2022-04-27	GNSSGenasys Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2022-03-15	GNSSGenasys Inc.A Award	Director	AAward	+30K sh	—	—	234,311
2022-02-23	GNSSGenasys Inc.S Sale	Director	SSale	−13.7K sh	$3.14	−$43.1K	204,311
2022-02-23	GNSSGenasys Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	0
2022-02-23	GNSSGenasys Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.16	+$43.2K	218,027
2022-01-31	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)A Award	Chief Financial Officer	AAward	+39.4K sh	—	—	39,360
2022-01-31	TVTXTravere Therapeutics, Inc. · Performance-based restricted stock unitsA Award	Chief Financial Officer	AAward	+8,000 sh	—	—	8,000
2022-01-31	TVTXTravere Therapeutics, Inc. · Performance-based restricted stock unitsA Award	Chief Financial Officer	AAward	+9,840 sh	—	—	9,840
2022-01-31	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+9,840 sh	—	—	39,093
2022-01-31	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,238 sh	$27.40	−$33.9K	37,855
2022-01-24	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,063 sh	$24.98	−$51.5K	29,253
2022-01-11	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−7,500 sh	$27.40	−$206K	31,316
2022-01-10	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+7,500 sh	—	—	38,816
2021-08-17	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,407 sh	$17.12	−$24.1K	31,316
2021-08-13	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+4,500 sh	—	—	32,723
2021-05-25	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.4K sh	—	—	15,402
2021-05-25	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+10.3K sh	—	—	47,501
2021-05-12	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$19.46	−$38.9K	28,223
2021-05-11	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$19.14	−$38.3K	30,223
2021-03-16	GNSSGenasys Inc.A Award	Director	AAward	+27.9K sh	—	—	168,027
2021-03-10	GNSSGenasys Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	0
2021-03-10	GNSSGenasys Inc.S Sale	Director	SSale	−5,456 sh	$7.42	−$40.5K	170,144
2021-03-10	GNSSGenasys Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.02	+$40.4K	175,600
2021-02-20	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+9,803 sh	—	—	37,159
2021-02-08	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,250 sh	$31.58	−$71.1K	32,223
2021-02-05	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,250 sh	$31.41	−$70.7K	34,473
2021-02-03	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+4,500 sh	—	—	36,723
2021-02-03	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,500 sh	$28.91	−$72.3K	33,348
2021-02-03	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,125 sh	$28.91	−$32.5K	32,223
2021-02-02	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,125 sh	$30.75	−$34.6K	35,848
2021-02-02	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,500 sh	$30.75	−$76.9K	36,973
2021-01-31	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+5,000 sh	—	—	39,473
2021-01-21	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+15K sh	—	—	34,473
2021-01-21	TVTXTravere Therapeutics, Inc. · Employee stock option (right to buy)A Award	Chief Financial Officer	AAward	+57.5K sh	—	—	57,500
2020-11-25	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,750 sh	$22.72	−$85.2K	19,473
2020-11-24	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,750 sh	$23.86	−$89.5K	23,223
2020-11-23	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+7,500 sh	—	—	26,973
2020-11-16	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−7,500 sh	$23.98	−$180K	19,473
2020-11-13	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−7,500 sh	$23.61	−$177K	26,973
2020-11-11	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+15K sh	—	—	34,473
2020-09-23	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$18.48	−$27.7K	19,473
2020-09-22	TVTXTravere Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$18.59	−$27.9K	20,973
2020-09-18	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+3,000 sh	—	—	22,473

Recent filings

Accepted (ET)
Jun 164
Clague Laura0001162194-23-000041
SEC(opens sec.gov)
Jun 174
Clague Laura0001162194-22-000075
SEC(opens sec.gov)
May 124
Clague Laura0001209191-22-028707
SEC(opens sec.gov)
Apr 274
Clague Laura0001437749-22-009944
SEC(opens sec.gov)
Mar 174
Clague Laura0001437749-22-006570
SEC(opens sec.gov)
Feb 244
Clague Laura0001437749-22-004289
SEC(opens sec.gov)
Feb 24
Clague Laura0001209191-22-006362
SEC(opens sec.gov)
Jan 264
Clague Laura0001209191-22-005080
SEC(opens sec.gov)
Jan 124
Clague Laura0001209191-22-003046
SEC(opens sec.gov)

Companies

Address

15378 AVENUE OF SCIENCE, SUITE 100

SAN DIEGO, CA, 92127